Swami, U., S. Goel and S. Mani, 2013. Therapeutic Targeting of CPT-11 induced diarrhea: A case for Prophylaxis. Curr. Drug Targets, 14: 777-797. PubMed |
Swami, U., G. Annunziata and I. Fulger, 2013. Experience with Vena Cava filters at a large community hospital and level I Trauma Center: Indications, complications and compliance barriers. Clin. Applied Thrombosis/Hemostasis. . PubMed |
Hou, J.Y., S. Aparo, M. Ghalib, I. Chaudhary and U. Shah et al., 2013. Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: A single institution experience from 1999 to 2010. Gynecol. Oncol., 131: 163-168. PubMed |
Swami, U., I. Chaudhary, M.H. Ghalib and S. Goel, 2012. Eribulin: A review of preclinical and clinical studies. Crit. Rev. Oncol. Hematol., 81: 163-184. PubMed |
Mani, S. and U. Swami, 2010. Eribulin mesilate, a halichondrin B analogue, in the treatment of breast cancer. Drugs Today, 46: 641-653. PubMed |